Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.

Abstract: To provide a composition for hair growth (hair growth agent) which has high hair growing effects and can be used for prevention or treatment of alopecia. The composition for hair growth comprises as an active ingredient at least one member selected from the group consisting of a compound represented by the formula (1) and a salt thereof. In the formula, R is a carboxy group or an alkoxycarbonyl group.

Abstract: A DC feeder voltage control apparatus includes a model-information storing unit storing train model information on each train running in a control section, substation model information on each substation, and feeding network model information in the control section, a fixed-voltage-value storing unit storing a fixed voltage value of a substation voltage set for each substation, a train-operation-state-information acquiring unit acquiring positions and operation state information on the trains running in the control section, a first-substation-voltage fixing unit outputting the fixed voltage value to two first substations located at both ends of the control section, and a second-substation-voltage calculating unit calculating a setting voltage value of the substation voltage in at least one second substation located between the two first substations based on the information, and substation voltages and substation currents of the first substations to output to the second substation.

Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.

Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.

Abstract: The invention provides a carburized part which has excellent medium-cycle fatigue strength in particular subjected to surface-hardening treatment by carburization. The invention provides a carburized part including a carburized layer formed by performing carburizing treatment to a steel, the steel including, in terms of % by mass: 0.15% to 0.25% of C, 0.15% or less of Si, 0.4% to 1.1% of Mn, 0.8% to 1.4% of Cr, 0.25% to 0.55% of Mo, 0.015% or less of P, and 0.035% or less of S, with the remainder being Fe and unavoidable impurities, and the steel satisfying the following relation; 0.10?[Mo]/(10[Si]+[Mn]+[Cr])?0.40, in which [M] represents a content of element M in terms of % by mass.

Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.

Abstract: A vehicular electronic control apparatus includes a mother unit having a microcomputer, a plurality of ECU modules connected to the mother unit detachably and configured to execute respective vehicle controls, an operation data communication section for communicating with the microcomputer operation data used by the plurality of ECU modules in executing respective control operation processing, and alternative operation execution section for causing at least one of the other ECU modules and the microcomputer to execute, as an alternative operation, at least a part of the arithmetic operation processing, which is to be executed by at least one of the plurality of the ECU modules.

Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.

Abstract: To deprotect an alcoholic hydroxyl group protected by a t-butyldimethylsilyl group without influencing a functional group unstable to an acid. In the presence of a solvent, an alcohol having a hydroxyl group protected by a t-butyldimethylsilyl group is deprotected in the presence of an acid or an acid salt having a pKa of from 1.0 to 3.0 in water.

Abstract: A charging apparatus includes a power receiving unit that includes a rectifier, receives AC power, and converts the AC power into DC power, a power storage device that has DC power stored therein, a DC/DC converter that can execute a bidirectional power-flow control including a control of charging to the power storage device and a control of discharging from the power storage device using an output of the rectifier, and a control unit that controls operations of the power receiving unit and the DC/DC converter. In the charging apparatus, an output voltage of the rectifier is set different from an output voltage of the DC/DC converter that is applied to an output terminal of the rectifier when the power storage device is discharged.

Abstract: A polishing pad which suppresses occurrence of a scratch or a roll-off on an object to be polished so that flatness is improved is provided. A polishing pad 1 is comprised a polyurethane sheet 2 having a polishing surface P for performing polishing processing to an object to be polished and an elastic sheet 3 having elasticity joined on a surface of the polyurethane sheet 2 on the opposite side to the polishing surface P. The polyurethane sheet 2 is set higher in compressibility than the elastic sheet 3, and is set lower in A hardness than the elastic sheet 3. The elastic sheet 3 is set at 1% or more in compressibility, and is set at 90 degrees or less in A hardness. Further, both of the polyurethane sheet 2 and the elastic sheet 3 are formed to have a thickness of 0.2 mm or more. The flexibility of the polyurethane sheet 2 is exerted during polishing processing so that the polyurethane sheet 2 deforms to press the polishing surface P approximately evenly on the object to be polished.

Abstract: A control circuit board has a plurality of connectors that can connect each control module circuit board to control a plurality of in-vehicle equipment. A power supply circuit board has a power supply circuit that controls a power supply from a battery to a controlled equipment of the control module circuit boards connected with each connector. The control circuit board and the power supply circuit board are electrically connected and accommodated in a case. When the control module circuit boards are connected with any connector of the control circuit board, the power supply circuit is controlled by the control module and it becomes possible to control the controlled equipment such as engines.

Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1 -4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.

Abstract: Multiple game machines communicating with one another progress a game while exchanging messages with one another. A screen showing the progress state of the game is displayed on a first LCD included in each game machine. When the progress state of the game displayed on the first LCD becomes a predetermined game situation, an icon prestored in association with the game situation is displayed in an icon display area provided on a second LCD having a touch panel provided on the front side thereof. When a player touches the displayed icon using a stylus, message buttons prestored in association with the game situation of the touched icon are displayed on the second LCD. When the player touches any one of the displayed message buttons with the stylus to select it, a message corresponding to the selected message button is input.

Abstract: A vehicular electronic control apparatus includes a mother unit having a microcomputer, a plurality of ECU modules connected to the mother unit detachably and configured to execute respective vehicle controls, an operation data communication section for communicating with the microcomputer operation data used by the plurality of ECU modules in executing respective control operation processing, and alternative operation execution section for causing at least one of the other ECU modules and the microcomputer to execute, as an alternative operation, at least a part of the arithmetic operation processing, which is to be executed by at least one of the plurality of the ECU modules.

Abstract: The present invention provides a technique for supporting accurate and smooth creation of a report. Information in which elements belonging to items included in a plurality of items of elements constructing a report are associated with each other between the items is stored in an input support database. Partial information corresponding to an extraction condition designated by an input from an input client by the user is extracted from the input support database and visually output (displayed) in a view in a report creating area.

Abstract: A control circuit board has a plurality of connectors that can connect each control module circuit board to control a plurality of in-vehicle equipment. A power supply circuit board has a power supply circuit that controls a power supply from a battery to a controlled equipment of the control module circuit boards connected with each connector. The control circuit board and the power supply circuit board are electrically connected and accommodated in a case. When the control module circuit boards are connected with any connector of the control circuit board, the power supply circuit is controlled by the control module and it becomes possible to control the controlled equipment such as engines.

Abstract: To improve game performance, in a three-dimensional video game in which a viewpoint position changes in accordance with a movement of a player character, considering an aspect of how to show a player an activation of a prescribed effect at a second object, forming a pair with a first object, for which the effect is set. In a case in which an action source object 201 and an action target object 202 are displayed, within a display range which changes in accordance with a movement of a player character, on a second LCD 12, on a front surface of which a touch panel is disposed, when a line drawing operation is carried out on the touch panel from a display position of the action source object 201 to a display position of the action target object 202, a speed at which the line drawing operation is being carried out is calculated.

Abstract: Provided is a compound represented by the formula (1): wherein R1 and R2 are each independently a hydrogen atom or a straight chain alkyl group having a carbon number of 1-3, R3 is a hydrogen atom, an alkyl group having a carbon number of 1-4, an alkoxyalkyl group, an aryl group, a halogen atom or a haloalkyl group, or a pharmaceutically acceptable salt thereof, which has, unlike known PGI2 analogs, a selective EP4 agonist action, and a medicament containing the compound, which is useful for the prophylaxis and/or treatment of immune diseases, diseases of the digestive tract, cardiovascular diseases, cardiac diseases, respiratory diseases, neurological diseases, ophthalmic diseases, renal diseases, hepatic diseases, bone diseases, skin diseases and the like.